2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, R Collins, M Antz, P Cornu, L Desteghe… - Ep …, 2021 - academic.oup.com
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, P Verhamme, TS Potpara… - European heart …, 2018 - academic.oup.com
The current manuscript is the second update of the original Practical Guide, published in
2013 [Heidbuchel et al. European Heart Rhythm Association Practical Guide on the use of …

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation

JG Andrade, M Aguilar, C Atzema, A Bell… - Canadian Journal of …, 2020 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial

SD Pokorney, GM Chertow, HR Al-Khalidi, D Gallup… - Circulation, 2022 - Am Heart Assoc
Background: There are no randomized data evaluating the safety or efficacy of apixaban for
stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial …

Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States

KC Siontis, X Zhang, A Eckard, N Bhave… - Circulation, 2018 - Am Heart Assoc
Background: Patients with end-stage kidney disease (ESKD) on dialysis were excluded from
clinical trials of direct oral anticoagulants for atrial fibrillation (AF). Recent data have raised …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

P Kirchhof, S Benussi, D Kotecha… - Polish Heart …, 2016 - journals.viamedica.pl
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

F Casselman, A Coca, R De Caterina, S Deftereos… - Europace, 2016 - cfewa.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Oral anticoagulation for patients with atrial fibrillation on long-term dialysis

T Kuno, H Takagi, T Ando, T Sugiyama… - Journal of the American …, 2020 - jacc.org
Background Patients on long-term dialysis are at increased risk of bleeding. Although oral
anticoagulants (OACs) are recommended for atrial fibrillation (AF) to reduce the risk of …

2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures

G Frendl, AC Sodickson, MK Chung, AL Waldo… - The Journal of thoracic …, 2014 - jtcvs.org
PREAMBLE Our mission was to develop evidence-based guidelines for the prevention and
treatment of perioperative/postoperative atrial fibrillation and flutter (POAF) for thoracic …

Hemodialysis tunneled catheter noninfectious complications

LM Miller, JM MacRae, M Kiaii, E Clark… - Canadian journal of …, 2016 - journals.sagepub.com
Noninfectious hemodialysis catheter complications include catheter dysfunction, catheter-
related thrombus, and central vein stenosis. The definitions, causes, and treatment …